Journey Medical Corp (DERM) stock
DERMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3033% below fair value
$3.90+0.20 (+5.41%)
Close on Nov 17, 2026Market cap $110.08MP/E –Yield –
Journey Medical price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Journey Medical's price to book ratio was 3.7× on Nov 11, 2026, against 7.2× a year earlier. Over the last 5 years it ranged from 0.7× to 10.4×, with a median of 5.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.7× | −3.2 |
| 2025 | Dec 31, 2025 | 6.9× | −0.2 |
| 2024 | Dec 31, 2024 | 7.1× | +1.3 |
| 2023 | Dec 29, 2023 | 5.8× | +4.6 |
| 2022 | Dec 30, 2022 | 1.2× | – |
See a number that looks wrong?